New Pill Appears Effective, Safe for Ulcerative Colitis: Study

Tofacitinib relieved symptoms in short term, but effects over time not yet known

HealthDay SHARE

But, Poles said he felt the study had a higher rate of adverse events than he likes to see, and he'd like to see long-term results. In addition, he noted, because there are other medications with a longer track record already available, he'd be hesitant to prescribe this new drug until he'd exhausted other options first.

"The drug is worthy of further study, but it may not be the panacea we hoped for," Poles said.

More information

Learn more about ulcerative colitis from the U.S. National Library of Medicine.

Copyright © 2012 HealthDay. All rights reserved.